United States

NuVasive Inc (NUVA.OQ)

NUVA.OQ on NASDAQ Stock Exchange Global Select Market

28 Apr 2017
Change (% chg)

$-0.30 (-0.41%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Select another date:

Wed, Mar 29 2017

BRIEF-NuVasive announces FDA 510(K) clearance of Coroent small interbody system

* NuVasive - announced fda 510(K) clearance of coroent small interbody system indicated for intervertebral body fusion at contiguous levels in cervical spine Source text for Eikon: Further company coverage:

BRIEF-Nuvasive sees FY 2017 revenue $1.065 bln

* Nuvasive inc - preliminary full year 2016 non-gaap operating profit margin expected to be in line with guidance of 16.0%

BRIEF-Nuvasive repurchased about $49.6 mln in aggregate principal amount of its 2.75 PCT convertible senior notes due 2017

* Nuvasive-From Nov 11 to nov 28, repurchased about $49.6 million in aggregate principal amount of its 2.75% convertible senior notes due 2017 - SEC filing

BRIEF-Jana Partners cuts sole share stake in Alphabet, takes sole share stake in Mondelez International

* Jana Partners LLC takes sole share stake of 111,127 shares in Sage Therapeutics Inc

Federal Circuit affirms invalidity of NuVasive spine implant patent

A U.S. appeals court on Wednesday upheld a decision by a patent appeal board holding most of a NuVasive Inc spine implant patent invalid, which NuVasive continued to appeal despite having settled with the company that originally challenged the patent, Medtronic Plc.

Select another date:

More From Around the Web